| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Esculentoside A |
商陸皂苷甲 |
65497-07-6 |
詳細(xì)
|
| (3bR-trans)-3b,4,5,9b,10,11-hexahydro-6-hydroxy-9b-methyl-7-(1-methylethyl)-phenanthro[1,2-c]furan-1(3H)-one |
(3bR-反式)-3b,4,5,9b,10,11-六氫-6-羥基-9b-甲基-7-(1-甲基乙基)-菲并[1,2-c]呋喃-1(3H)-酮 |
74285-86-2 |
詳細(xì)
|
| (R)-(+)-Corypalmine |
D-四氫藥根堿 |
13063-54-2 |
詳細(xì)
|
| Tussilagone |
款冬酮 |
104012-37-5 |
詳細(xì)
|
| Heteroclitin D(Standard Reference Material) |
異型南五味子丁素 |
140369-76-2 |
詳細(xì)
|
| Tetrahydroberberine |
四氫小檗堿 |
522-97-4 |
詳細(xì)
|
| SBE 13 hydrochloride |
SBE13鹽酸鹽 |
1052532-15-6 |
詳細(xì)
|
| A -18 |
酪氨酸磷酸化抑制劑23 |
118409-57-7 |
詳細(xì)
|
| PQ401 |
IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-N渭-(2-methylquinolin-4-yl)urea |
196868-63-0 |
詳細(xì)
|
| Clinafloxacin |
克林沙星 |
105956-97-6 |
詳細(xì)
|
| PJ-34 |
PJ34 HCl 游離 |
344458-19-1 |
詳細(xì)
|
| SC 66 |
|
871361-88-5 |
詳細(xì)
|
| HSF1A |
|
1196723-93-9 |
詳細(xì)
|
| 1175526-27-8 |
|
1175526-27-8 |
詳細(xì)
|
| Tar ocil |
|
1200443-21-5 |
詳細(xì)
|
| Scopolamine butylbromide |
N-丁基共聚溴化銨 |
149-64-4 |
詳細(xì)
|
| MX-69 |
|
1005264-47-0 |
詳細(xì)
|
| SU5201 |
|
114727-43-4 |
詳細(xì)
|
| AP-761 |
2 - [ 4- [ 4 -(三氟甲基)苯甲酰胺基] ] ]苯甲基4,6 -二(二甲氨基) -嘧啶-5-乙酸 |
1093108-50-9 |
詳細(xì)
|
| FASORACETAM |
法索西坦 |
110958-19-5 |
詳細(xì)
|
| ASP-9521 |
1-[1-[(5-甲氧基-1H-吲哚-2-基)羰基]哌啶-4-基]-2-甲基丙-2-醇 |
1126084-37-4 |
詳細(xì)
|
| Ralinepag |
|
1187856-49-0 |
詳細(xì)
|
| exo-IWR 1 |
|
1127442-87-8 |
詳細(xì)
|
| DASa-58 |
3-[[4-[(2,3-二氫-1,4-苯并二惡英-6-基)磺?；鵠六氫-1H-1,4-二氮雜卓-1-基]磺酰基]苯胺 |
1203494-49-8 |
詳細(xì)
|
| A 804598 |
|
1125758-85-1 |
詳細(xì)
|
| IRAK inhibitor 6 |
N-[2-甲氧基-4-(4-嗎啉基)苯基]-2-(3-吡啶基)-4-噻唑甲酰 |
1042672-97-8 |
詳細(xì)
|
| Talniflumate |
他尼氟酯Talniflumate |
66898-62-2 |
詳細(xì)
|
| SR1001 |
|
1335106-03-0 |
詳細(xì)
|
| DC-05 |
|
890643-16-0 |
詳細(xì)
|
| LDN-212320 |
|
894002-50-7 |
詳細(xì)
|
| Retro-2cycl |
|
1429192-00-6 |
詳細(xì)
|
| KY 05009 |
|
1228280-29-2 |
詳細(xì)
|
| YHO-13177 |
|
912287-56-0 |
詳細(xì)
|
| YK 3-237 |
|
1215281-19-8 |
詳細(xì)
|
| DUBs-IN-3 |
9-[(2-丙烯-1-氧基)亞氨基]-9H-茚并[1,2-B]吡嗪-2,3-二甲腈 |
924296-17-3 |
詳細(xì)
|
| FGH-10019 |
|
1046045-61-7 |
詳細(xì)
|
| BETAZOLE HYDROCHLORIDE |
鹽酸倍他唑 |
138-92-1 |
詳細(xì)
|
| Poricoic acid A(F) |
茯苓酸A |
137551-38-3 |
詳細(xì)
|
| 2-(2-(1-naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic acid |
司替匹侖 |
866460-33-5 |
詳細(xì)
|
| Norgestimate |
炔諾肟酯 |
35189-28-7 |
詳細(xì)
|
| Topiramate |
托吡酯 |
97240-79-4 |
詳細(xì)
|
| D-erythro-Hex-2-enonic acid, g-lactone, monosodium salt |
異抗壞血酸鈉 |
6381-77-7 |
詳細(xì)
|
| Inosine, compd. with 1-(dimethylamino)-2-propanol4-(acetylamino)benzoate (salt) (1:3)OTHER CA INDEX NAMES:2-Propanol, 1-(dimethylamino)-, 4-(acetylamino)benzoate (salt),compd. with inosine (3:1)Benzoic acid, 4-(acetylamino)-, compd. with1-(dimethylamino)-2-propanol and inosine (3:3:1) |
異丙肌苷 |
36703-88-5 |
詳細(xì)
|
| Cyclic Somatostatin |
合成生長(zhǎng)抑素 |
38916-34-6 |
詳細(xì)
|
| sitravatinib |
|
1123837-84-2 |
詳細(xì)
|
| N-(Benzo[d]isoxazol-3-yl)-4-methylbenzamide |
|
891025-25-5 |
詳細(xì)
|
| Vonoprazan |
沃諾拉贊 |
881681-00-1 |
詳細(xì)
|
| URB937 |
|
1357160-72-5 |
詳細(xì)
|
| Walrycin B |
|
878419-78-4 |
詳細(xì)
|
| 2-(4-Isopropylpheny)-4H-chroMen-4-one |
|
92831-11-3 |
詳細(xì)
|
| 5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[2-(morpholin-4-yl)ethyl]-2-[2-(4-propoxyphenyl)ethyl]-1H-1,3-benzodiazole |
|
2070014-93-4 |
詳細(xì)
|
| AZD1283 |
|
919351-41-0 |
詳細(xì)
|
| IOX2 |
|
931398-72-0 |
詳細(xì)
|
| 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenylpropan-1-one |
普羅帕酮 |
54063-53-5 |
詳細(xì)
|
| 4-((3,5-Dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid |
化合物ZL006 |
1181226-02-7 |
詳細(xì)
|
| H-ILE-TRP-OH |
|
13589-06-5 |
詳細(xì)
|
| STF-118804 |
煙酰胺磷酸核糖基轉(zhuǎn)移酶 |
894187-61-2 |
詳細(xì)
|
| B 45, HDAC3 Inhibitor |
|
926259-99-6 |
詳細(xì)
|
| N-Cycloheptyl-2-(4,5-dihydro-1H-imidazol-2-ylsulfanyl)acetamide hydrochloride |
ICCB-19鹽酸鹽 |
1803605-68-6 |
詳細(xì)
|
| UK-371804 |
化合物UK371804 |
256477-09-5 |
詳細(xì)
|
| DFHBI |
|
1241390-29-3 |
詳細(xì)
|
| Dirithromycin |
地紅霉素 |
62013-04-1 |
詳細(xì)
|
| SMER 28 |
|
307538-42-7 |
詳細(xì)
|
| LDN212854 |
|
1432597-26-6 |
詳細(xì)
|
| (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate |
|
1373431-65-2 |
詳細(xì)
|
| 4-Oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate |
|
877636-42-5 |
詳細(xì)
|
| Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(1-cyclohexen-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-(2-pyridinylamino)- |
|
2201056-66-6 |
詳細(xì)
|
| R-Avanafil |
4-[[(3-氯-4-甲氧基苯基)甲基]氨基]-2-[(2R)-2-(羥甲基)-1-吡咯烷基]-N-(2-嘧啶基甲基)-5-嘧啶甲酰胺 |
1638497-26-3 |
詳細(xì)
|
| PF 04995274 |
|
1331782-27-4 |
詳細(xì)
|
| 1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
雷芬那辛 |
864750-70-9 |
詳細(xì)
|
| EFONIDIPINE |
依福地平 |
111011-76-8 |
詳細(xì)
|
| 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide |
6-[[3-[(二甲基氨基)羰基]苯基]磺酰]-4-[(3-甲氧基苯基)氨基]-8-甲基-3-喹啉甲酰胺 |
801312-28-7 |
詳細(xì)
|
| (R)-5-(4-AMINO-3-METHYL-PHENYL)-8-METHYL-7-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]-BENZODIAZEPINE |
|
732278-52-3 |
詳細(xì)
|
| S-Ruxolitinib (INCB018424) |
S-魯索替尼 |
941685-37-6 |
詳細(xì)
|
| Basmisanil |
巴米沙尼 |
1159600-41-5 |
詳細(xì)
|
| Radotinib |
拉多替尼 |
926037-48-1 |
詳細(xì)
|
| EFONIDIPINE |
依福地平 |
111011-63-3 |
詳細(xì)
|
| Neratinib maleate |
馬來酸來那替尼 |
915942-22-2 |
詳細(xì)
|
| LY 294002 |
LY-294,002鹽酸鹽 |
934389-88-5 |
詳細(xì)
|
| (-)-MK-801 MALEATE |
(+)-MK 801 順丁烯二酸鹽 |
77086-22-7 |
詳細(xì)
|
| (2R)-1,1,1-Trifluoro-2-[3-[(2R)-4-[4-fluoro-2-(trifluoromethyl)phenyl]-2-methylpiperazin-1-yl]sulfonylphenyl]propan-2-ol |
|
946396-92-5 |
詳細(xì)
|
| "(R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide " |
2(4-環(huán)丙基苯基)-N[(1R)- 1 -[5 -(2,2,2-三氟乙氧基)吡啶-2-基]乙基]乙酰胺 |
953778-63-7 |
詳細(xì)
|
| 5-(2-AMINO-4-OXO-3-(2-(TRIFLUOROMETHYL)PHENYL)-3,4-DIHYDROQUIZOLIN-6-YL)-N-(2,4-DIFLUOROPHENYL)-2-METHOXYPYRIDINE-3-SULFOMIDE |
|
1384097-27-1 |
詳細(xì)
|
| Cridanimod |
|
1446418-48-9 |
詳細(xì)
|
| (R)-(+)-8-methyl-5-(3-methyl-4-nitrophenyl)-8,9-dihydro-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine |
|
732277-05-3 |
詳細(xì)
|
| RETAPAMULIN |
瑞他莫林 |
224452-66-8 |
詳細(xì)
|
| RILPIVIRINE HCL |
鹽酸利匹韋林 |
700361-47-3 |
詳細(xì)
|
| (+)-5-(4-amino-3-methylphenyl)-7-(2-thiazolyl)-8,9-dihydro-7H-1,3-dioxolo-[4,5-h][2,3]benzodiazepine |
(R)-2-甲基-4-(8-甲基-7-(1,3,4-噻二唑-2-基)-8,9-二氫-7H-[1,3]二氧戊環(huán)并[4',5':4,5]苯并[1,2-D][1,2]二氮雜-5-基)苯胺 |
923272-18-8 |
詳細(xì)
|
| 4-Acetamido-N-(2-amino-4-fluorophenyl)benzamide |
|
1550053-02-5 |
詳細(xì)
|
| Telotristat |
|
1033805-28-5 |
詳細(xì)
|
| Picfeltarraenin IA |
苦玄參苷IA |
97230-47-2 |
詳細(xì)
|
| AB 1010 Mesylate |
馬賽替尼 |
1048007-93-7 |
詳細(xì)
|
| Shield-1 |
化合物SHIELD-1 |
914805-33-7 |
詳細(xì)
|
| BTYNB |
2-(((5-溴噻吩-2-基)亞甲基)氨基)苯甲酰胺 |
304456-62-0 |
詳細(xì)
|
| GSK620 |
|
2088410-46-0 |
詳細(xì)
|
| AT-101 |
|
866541-93-7 |
詳細(xì)
|
| DUBs-IN-2 |
9-乙氧基亞氨基-9H-茚并[1,2-B]吡嗪-2,3-二甲腈 |
924296-19-5 |
詳細(xì)
|
| CDK-IN-2 |
|
1269815-17-9 |
詳細(xì)
|
| mavacoxib |
嗎伐考昔 |
170569-88-7 |
詳細(xì)
|
| 1-BCP |
|
34023-62-6 |
詳細(xì)
|